1 Dolutegravir Market Overview 1.1 Dolutegravir Product Overview 1.2 Dolutegravir Market Segment by Type 1.2.1 10mg Tablets 1.2.2 50mg Tablets 1.3 Global Dolutegravir Market Size by Type 1.3.1 Global Dolutegravir Market Size Overview by Type (2016-2027) 1.3.2 Global Dolutegravir Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Dolutegravir Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Dolutegravir Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Dolutegravir Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Dolutegravir Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Dolutegravir Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Dolutegravir Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Dolutegravir Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Dolutegravir Sales Breakdown by Type (2016-2021) 1.4.2 Europe Dolutegravir Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Dolutegravir Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Dolutegravir Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Dolutegravir Sales Breakdown by Type (2016-2021) 2 Global Dolutegravir Market Competition by Company 2.1 Global Top Players by Dolutegravir Sales (2016-2021) 2.2 Global Top Players by Dolutegravir Revenue (2016-2021) 2.3 Global Top Players Dolutegravir Price (2016-2021) 2.4 Global Top Manufacturers Dolutegravir Manufacturing Base Distribution, Sales Area, Product Type 2.5 Dolutegravir Market Competitive Situation and Trends 2.5.1 Dolutegravir Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Dolutegravir Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dolutegravir as of 2020) 2.7 Date of Key Manufacturers Enter into Dolutegravir Market 2.8 Key Manufacturers Dolutegravir Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Dolutegravir Status and Outlook by Region 3.1 Global Dolutegravir Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Dolutegravir Historic Market Size by Region 3.2.1 Global Dolutegravir Sales in Volume by Region (2016-2021) 3.2.2 Global Dolutegravir Sales in Value by Region (2016-2021) 3.2.3 Global Dolutegravir Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Dolutegravir Forecasted Market Size by Region 3.3.1 Global Dolutegravir Sales in Volume by Region (2022-2027) 3.3.2 Global Dolutegravir Sales in Value by Region (2022-2027) 3.3.3 Global Dolutegravir Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Dolutegravir by Application 4.1 Dolutegravir Market Segment by Application 4.1.1 Prevent HIV Infection Following Potential Exposure 4.1.2 Other 4.2 Global Dolutegravir Market Size by Application 4.2.1 Global Dolutegravir Market Size Overview by Application (2016-2027) 4.2.2 Global Dolutegravir Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Dolutegravir Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Dolutegravir Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Dolutegravir Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Dolutegravir Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Dolutegravir Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Dolutegravir Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Dolutegravir Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Dolutegravir Sales Breakdown by Application (2016-2021) 4.3.2 Europe Dolutegravir Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Dolutegravir Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Dolutegravir Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Dolutegravir Sales Breakdown by Application (2016-2021) 5 North America Dolutegravir by Country 5.1 North America Dolutegravir Historic Market Size by Country 5.1.1 North America Dolutegravir Sales in Volume by Country (2016-2021) 5.1.2 North America Dolutegravir Sales in Value by Country (2016-2021) 5.2 North America Dolutegravir Forecasted Market Size by Country 5.2.1 North America Dolutegravir Sales in Volume by Country (2022-2027) 5.2.2 North America Dolutegravir Sales in Value by Country (2022-2027) 6 Europe Dolutegravir by Country 6.1 Europe Dolutegravir Historic Market Size by Country 6.1.1 Europe Dolutegravir Sales in Volume by Country (2016-2021) 6.1.2 Europe Dolutegravir Sales in Value by Country (2016-2021) 6.2 Europe Dolutegravir Forecasted Market Size by Country 6.2.1 Europe Dolutegravir Sales in Volume by Country (2022-2027) 6.2.2 Europe Dolutegravir Sales in Value by Country (2022-2027) 7 Asia-Pacific Dolutegravir by Region 7.1 Asia-Pacific Dolutegravir Historic Market Size by Region 7.1.1 Asia-Pacific Dolutegravir Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Dolutegravir Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Dolutegravir Forecasted Market Size by Region 7.2.1 Asia-Pacific Dolutegravir Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Dolutegravir Sales in Value by Region (2022-2027) 8 Latin America Dolutegravir by Country 8.1 Latin America Dolutegravir Historic Market Size by Country 8.1.1 Latin America Dolutegravir Sales in Volume by Country (2016-2021) 8.1.2 Latin America Dolutegravir Sales in Value by Country (2016-2021) 8.2 Latin America Dolutegravir Forecasted Market Size by Country 8.2.1 Latin America Dolutegravir Sales in Volume by Country (2022-2027) 8.2.2 Latin America Dolutegravir Sales in Value by Country (2022-2027) 9 Middle East and Africa Dolutegravir by Country 9.1 Middle East and Africa Dolutegravir Historic Market Size by Country 9.1.1 Middle East and Africa Dolutegravir Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Dolutegravir Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Dolutegravir Forecasted Market Size by Country 9.2.1 Middle East and Africa Dolutegravir Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Dolutegravir Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Dolutegravir Business 10.1 ViiV Healthcare (GSK) 10.1.1 ViiV Healthcare (GSK) Corporation Information 10.1.2 ViiV Healthcare (GSK) Introduction and Business Overview 10.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue and Gross Margin (2016-2021) 10.1.4 ViiV Healthcare (GSK) Dolutegravir Products Offered 10.1.5 ViiV Healthcare (GSK) Recent Development 10.2 Shanghai Desano Pharmaceuticals 10.2.1 Shanghai Desano Pharmaceuticals Corporation Information 10.2.2 Shanghai Desano Pharmaceuticals Introduction and Business Overview 10.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue and Gross Margin (2016-2021) 10.2.4 ViiV Healthcare (GSK) Dolutegravir Products Offered 10.2.5 Shanghai Desano Pharmaceuticals Recent Development 10.3 Mylan 10.3.1 Mylan Corporation Information 10.3.2 Mylan Introduction and Business Overview 10.3.3 Mylan Dolutegravir Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Mylan Dolutegravir Products Offered 10.3.5 Mylan Recent Development 10.4 Aurobindo Pharma 10.4.1 Aurobindo Pharma Corporation Information 10.4.2 Aurobindo Pharma Introduction and Business Overview 10.4.3 Aurobindo Pharma Dolutegravir Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Aurobindo Pharma Dolutegravir Products Offered 10.4.5 Aurobindo Pharma Recent Development 10.5 LAURUS Labs 10.5.1 LAURUS Labs Corporation Information 10.5.2 LAURUS Labs Introduction and Business Overview 10.5.3 LAURUS Labs Dolutegravir Sales, Revenue and Gross Margin (2016-2021) 10.5.4 LAURUS Labs Dolutegravir Products Offered 10.5.5 LAURUS Labs Recent Development 10.6 Adcock Ingram Limited 10.6.1 Adcock Ingram Limited Corporation Information 10.6.2 Adcock Ingram Limited Introduction and Business Overview 10.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Adcock Ingram Limited Dolutegravir Products Offered 10.6.5 Adcock Ingram Limited Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Dolutegravir Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Dolutegravir Industrial Chain Analysis 11.4 Dolutegravir Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Dolutegravir Distributors 12.3 Dolutegravir Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 10mg Tablets Table 2. Major Company of 50mg Tablets Table 3. Global Dolutegravir Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Dolutegravir Sales by Type (2016-2021) & (K Pcs) Table 5. Global Dolutegravir Sales Market Share in Volume by Type (2016-2021) Table 6. Global Dolutegravir Sales by Type (2016-2021) & (US& Million) Table 7. Global Dolutegravir Market Share in Value by Type (2016-2021) Table 8. Global Dolutegravir Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Dolutegravir Sales by Type (2022-2027) & (K Pcs) Table 10. Global Dolutegravir Sales Market Share in Volume by Type (2022-2027) Table 11. Global Dolutegravir Sales by Type (2022-2027) & (US$ Million) Table 12. Global Dolutegravir Sales Market Share in Value by Type (2022-2027) Table 13. Global Dolutegravir Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Dolutegravir Sales by Type (2016-2021) & (K Pcs) Table 15. North America Dolutegravir Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Dolutegravir Sales (K Pcs) by Type (2016-2021) Table 17. Europe Dolutegravir Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Dolutegravir Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Dolutegravir Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Dolutegravir Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Dolutegravir Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Dolutegravir Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Dolutegravir Sales by Type (2016-2021) & (US$ Million) Table 24. Global Dolutegravir Sales by Company (2016-2021) & (K Pcs) Table 25. Global Dolutegravir Sales Share by Company (2016-2021) Table 26. Global Dolutegravir Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Dolutegravir Revenue Share by Company (2016-2021) Table 28. Global Market Dolutegravir Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Dolutegravir Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Dolutegravir Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dolutegravir as of 2020 Table 32. Date of Key Manufacturers Enter into Dolutegravir Market Table 33. Key Manufacturers Dolutegravir Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Dolutegravir Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Dolutegravir Sales by Region (2016-2021) & (K Pcs) Table 37. Global Dolutegravir Sales Market Share in Volume by Region (2016-2021) Table 38. Global Dolutegravir Sales by Region (2016-2021) & (US$ Million) Table 39. Global Dolutegravir Sales Market Share in Value by Region (2016-2021) Table 40. Global Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Dolutegravir Sales by Region (2022-2027) & (K Pcs) Table 42. Global Dolutegravir Sales Market Share in Volume by Region (2022-2027) Table 43. Global Dolutegravir Sales by Region (2022-2027) & (US$ Million) Table 44. Global Dolutegravir Sales Market Share in Value by Region (2022-2027) Table 45. Global Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Dolutegravir Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Dolutegravir Sales by Application (2016-2021) & (K Pcs) Table 48. Global Dolutegravir Sales Market Share in Volume by Application (2016-2021) Table 49. Global Dolutegravir Sales by Application (2016-2021) & (US$ Million) Table 50. Global Dolutegravir Sales Market Share in Value by Application (2016-2021) Table 51. Global Dolutegravir Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Dolutegravir Sales by Application (2022-2027) & (K Pcs) Table 53. Global Dolutegravir Sales Market Share in Volume by Application (2022-2027) Table 54. Global Dolutegravir Sales by Application (2022-2027) & (US$ Million) Table 55. Global Dolutegravir Sales Market Share in Value by Application (2022-2027) Table 56. Global Dolutegravir Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Dolutegravir Sales by Application (2016-2021) (K Pcs) Table 58. North America Dolutegravir Sales by Application (2016-2021) & (US$ Million) Table 59. North America Dolutegravir Sales Market Share in Value by Application in 2020 Table 60. Europe Dolutegravir Sales by Application (2016-2021) (K Pcs) Table 61. Europe Dolutegravir Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Dolutegravir Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Dolutegravir Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Dolutegravir Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Dolutegravir Sales Market Share in Value by Application in 2020 Table 66. Latin America Dolutegravir Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Dolutegravir Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Dolutegravir Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Dolutegravir Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Dolutegravir Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Dolutegravir Sales Market Share in Value by Application in 2020 Table 72. North America Dolutegravir Sales by Country (2016-2021) & (K Pcs) Table 73. North America Dolutegravir Sales Market Share in Volume by Country (2016-2021) Table 74. North America Dolutegravir Sales by Country (2016-2021) & (US$ Million) Table 75. North America Dolutegravir Sales Market Share in Value by Country (2016-2021) Table 76. North America Dolutegravir Sales by Country (2022-2027) & (K Pcs) Table 77. North America Dolutegravir Sales Market Share in Volume by Country (2022-2027) Table 78. North America Dolutegravir Sales by Country (2022-2027) & (US$ Million) Table 79. North America Dolutegravir Sales Market Share in Value by Country (2022-2027) Table 80. Europe Dolutegravir Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Dolutegravir Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Dolutegravir Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Dolutegravir Sales Market Share in Value by Country (2016-2021) Table 84. Europe Dolutegravir Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Dolutegravir Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Dolutegravir Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Dolutegravir Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Dolutegravir Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Dolutegravir Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Dolutegravir Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Dolutegravir Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Dolutegravir Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Dolutegravir Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Dolutegravir Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Dolutegravir Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Dolutegravir Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Dolutegravir Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Dolutegravir Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Dolutegravir Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Dolutegravir Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Dolutegravir Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Dolutegravir Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Dolutegravir Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Dolutegravir Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Dolutegravir Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Dolutegravir Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Dolutegravir Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Dolutegravir Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Dolutegravir Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Dolutegravir Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Dolutegravir Sales Market Share in Value by Country (2022-2027) Table 112. ViiV Healthcare (GSK) Corporation Information Table 113. ViiV Healthcare (GSK) Introduction and Business Overview Table 114. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. ViiV Healthcare (GSK) Dolutegravir Product Table 116. ViiV Healthcare (GSK) Recent Development Table 117. Shanghai Desano Pharmaceuticals Corporation Information Table 118. Shanghai Desano Pharmaceuticals Introduction and Business Overview Table 119. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. Shanghai Desano Pharmaceuticals Dolutegravir Product Table 121. Shanghai Desano Pharmaceuticals Recent Development Table 122. Mylan Corporation Information Table 123. Mylan Introduction and Business Overview Table 124. Mylan Dolutegravir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 125. Mylan Dolutegravir Product Table 126. Mylan Recent Development Table 127. Aurobindo Pharma Corporation Information Table 128. Aurobindo Pharma Introduction and Business Overview Table 129. Aurobindo Pharma Dolutegravir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 130. Aurobindo Pharma Dolutegravir Product Table 131. Aurobindo Pharma Recent Development Table 132. LAURUS Labs Corporation Information Table 133. LAURUS Labs Introduction and Business Overview Table 134. LAURUS Labs Dolutegravir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 135. LAURUS Labs Dolutegravir Product Table 136. LAURUS Labs Recent Development Table 137. Adcock Ingram Limited Corporation Information Table 138. Adcock Ingram Limited Introduction and Business Overview Table 139. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 140. Adcock Ingram Limited Dolutegravir Product Table 141. Adcock Ingram Limited Recent Development Table 142. Key Raw Materials Lists Table 143. Raw Materials Key Suppliers Lists Table 144. Dolutegravir Market Trends Table 145. Dolutegravir Market Drivers Table 146. Dolutegravir Market Challenges Table 147. Dolutegravir Market Restraints Table 148. Dolutegravir Distributors List Table 149. Dolutegravir Downstream Customers Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Dolutegravir Product Picture Figure 2. Global Dolutegravir Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Dolutegravir Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Dolutegravir Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 10mg Tablets Figure 6. Global 10mg Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 50mg Tablets Figure 8. Global 50mg Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Dolutegravir Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Dolutegravir Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Dolutegravir Sales Market Share in Value by Type (2016-2021) Figure 12. Global Dolutegravir Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Dolutegravir Sales Market Share in Value by Type (2022-2027) Figure 14. North America Dolutegravir Sales Market Share in Volume by Type in 2020 Figure 15. North America Dolutegravir Sales Market Share in Value by Type in 2020 Figure 16. Europe Dolutegravir Sales Market Share in Volume by Type in 2020 Figure 17. Europe Dolutegravir Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Dolutegravir Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Dolutegravir Sales Market Share in Value by Type in 2020 Figure 20. Latin America Dolutegravir Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Dolutegravir Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Dolutegravir Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Dolutegravir Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dolutegravir Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Dolutegravir Revenue in 2020 Figure 26. Dolutegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Prevent HIV Infection Following Potential Exposure Figure 28. Global Prevent HIV Infection Following Potential Exposure Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Other Figure 30. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Global Dolutegravir Sales by Application (2016-2027) & (US$ Million) Figure 32. Global Dolutegravir Sales Market Share in Volume by Application (2016-2021) Figure 33. Global Dolutegravir Sales Market Share in Value by Application (2016-2021) Figure 34. Global Dolutegravir Sales Market Share in Volume by Application (2022-2027) Figure 35. North America Dolutegravir Sales Market Share in Volume by Application in 2020 Figure 36. Latin America Dolutegravir Sales Market Share in Value by Application in 2020 Figure 37. Middle East and Africa Dolutegravir Sales Market Share in Value by Application in 2020 Figure 38. Key Raw Materials Price Figure 39. Dolutegravir Manufacturing Cost Structure Figure 40. Dolutegravir Industrial Chain Analysis Figure 41. Channels of Distribution Figure 42. Distributors Profiles Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

ViiV Healthcare (GSK) Shanghai Desano Pharmaceuticals Mylan Aurobindo Pharma LAURUS Labs Adcock Ingram Limited